OSA, hyperlipidemia, CVD) Main exclusion criteria Diabetes HbA1c 6.5% Previous obesity surgery History of chronic pancreatitis Acute pancreatitis within 180 days Baseline characteristics Average age 46 years Female sex - 74% Average weight - 231 lbs (105 kg) Average BMI - 38 Randomized treatment groups Group 1 (1306 patients): Wegovy 2.4 mg subcutaneously once weekly Group 2 (655 patients): Placebo Wegovy was started at a dose of 0.25 mg once weekly and increased every 4 weeks over a period of 16 weeks to a target dose of 2.4 mg once weekly All patients also received diet and exercise counseling Coprimary endpoints were the percentage change in body weight from baseline to week 68 and achievement of a reduction in body weight of 5% or more from baseline to week 68 Primary outcome: Results In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight
The how long does compounded semaglutide last in the fridge information helps you understand storage limits
Advantages include established relationship and familiarity with your medical history, coordination with your overall healthcare, ability to manage routine prescriptions and monitoring, and often shorter wait times than specialists
The mailer-inside-a-mailer setup works for shipping, not for temperature control
Various factors including age, sex, body composition, kidney function, and concurrent medications all influence how you'll respond to treatment
Notification is always best given by telephone 07845 074565 or if there are difficulties with you doing so, then by email at [email protected]
